Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1201101 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Yingzhi Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disord…. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, COVID-19, Hepatitis B. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Inactivated SARS-CoV-2 vaccination has recently been approved for children aged 3-17 years in China. However, data on long-term humoral responses to inactivated vaccines in children with chronic hepatitis B (CHB) are still limited.
Methods
In this prospective observational study, CHB children after primary inactivated SARS-CoV-2 vaccines were recruited consecutively and followed up for 1 year. CHB adults from another cohort study (NCT05007665) were used as a control. The receptor-binding domain IgG antibody (anti-RBD-IgG), neutralizing antibody (NAb), neutralization against Omicron (BA2.12.1, BA.4 and BA.5), and memory B -cell (MBC) responses were evaluated.
Results
Overall, 115 CHB children and 351 CHB adults were included in this analysis. The antibody titers decreased over the first ~180 days and then plateaued up to 1 year in CHB children. However, lower and faster declines in antibody responses were observed in CHB adults. Interestingly, the seroprevalence of antibodies was still high after over 8 months in CHB children (anti-RBD-IgG [90%] and NAbs [83%]). However, neutralization against Omicron subvariants was significantly reduced in CHB children (-3.68-fold to -8.60-fold). Notably, neutralization against the BA.5 subvariant was obviously diminished in CHB children compared with adults. Moreover, CHB children had similar RBD-specific MBCs but higher RBD-specific atypical MBCs compared with adults.
Conclusion
Inactivated vaccination could elicit more robust and durable antibody responses to the wild-type SARS-CoV-2 strain in CHB children than in CHB adults but showed inferior responses to Omicron subvariants (especially to the BA.5 strain). Hence, new Omicron-related or all-in-one vaccines are needed immediately for CHB children.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Dis…
- Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, the Second Affiliated Hospital, Chongqing Medical University, Chongqi…
Zitieren
APA
Zhou, Y., Chen, Z., He, Y., Peng, X., Chang, Y., Tan, A., Li, H., Cai, D., Hu, P., Chen, M., Peng, M., Xu, H., & Ren, H. (2023). Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1201101
Vancouver
Zhou Y, Chen Z, He Y, Peng X, Chang Y, Tan A, et al. Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1201101
BibTeX
@article{Zhou2023,
author = {Zhou, Yingzhi and Chen, Zhiwei and He, Yi and Peng, Xiaorong and Chang, Yunan and Tan, Aoxue and Li, Hu and Cai, Dachuan and Hu, Peng and Chen, Min and Peng, Mingli and Xu, Hongmei and Ren, Hong},
title = {Humoral immune responses to inactivated COVID-19 vaccine up to 1 year in children with chronic hepatitis B infection},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1201101}
}
EUVIMED